Tag: amos bairoch & lydie lane group

SIB’s mission, as per its mandate from the Secretariat for Education, Research and Innovation SERI, is to be a provider of long-term, high-impact infrastructure for the life sciences and the biomedical world.

Two further resources developed by SIB Groups have been designated as of crucial importance for life sciences, as a result of the latest edition of the selection process led by ELIXIR at the European level: Cellosaurus and Rhea.

The Human Proteome Project (HPP) of the Human Proteome Organisation (HUPO) is ten years old. Its mission? To generate the map of the protein-based molecular architecture of the human body.

The SIB CALIPHO Group and ENYO Pharma SA worked hand-in-hand in a transnational public-private partnership (PPP) to make human protein interaction data publicly available and FAIR, through the SIB Resource neXtProt.

Last week, we announced a series of communications highlighting SIB’s development axes for the years to come. Leveraging the biocuration expertise of the Institute in the context of personalized health is one of them...

What we do We aim to use a combination of bioinformatics and experimental methodologies to increase knowledge about the function of the 20,000 protein-coding genes in the human genome. Our main mission is the development of neXtProt, a human...

Amos Bairoch, co-founder of the SIB Swiss Institute of Bioinformatics and Group Leader of the CALIPHO group, is the 2018 awardee for Outstanding Contributions to Biomolecular Technologies of the prestigious Association of Biomolecular Resource...

Identifying and supporting SIB Resources Every four years, the Institute’s External Scientific Advisory Board (SAB) provides recommendations on the portfolio of SIB-supported Resources. By taking into account competitive criteria – such as the...